← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

158

Price

$0

Filed

Feb 25

Insider

Name

Fitzgerald Kevin Joseph

Title

CSO & EVP, Head of Research

CIK

0001886431

Roles

Officer

Transaction Details

Transaction Date

2026-02-23

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

21,422

Footnotes

On February 23, 2026, the People, Culture, and Compensation Committee of the issuer approved the issuance of shares of Company common stock having an aggregate value of USD $100,000 to each employee who completes 20 consecutive years of employment. The shares issued and reported here on Form 4, net of the minimum statutory tax liability, were issued to the reporting person in recognition of 20 years of continuous employment on December 5, 2025. | Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.

Filing Info

Accession No.

0001735276-26-000032

Form Type

4

Issuer CIK

0001178670

Fitzgerald Kevin Joseph's History

Date Ticker Type Value
2026-04-07 OVID A $45K
2026-03-05 ALNY $40K
2026-03-05 ALNY $75K
2026-03-05 ALNY $48K
2026-03-05 ALNY $50K
2026-03-04 ALNY $9K
2026-03-04 ALNY $9K
2026-03-04 ALNY $19K
2026-03-04 ALNY $25K
2026-03-04 ALNY $31K

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06